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Salmonella enterica serovar Virchow usually causes mild gastroenteritis in humans; how-
ever, it is frequently invasive and many isolates are resistant to a broad-range of therapeutic
antimicrobials. Poultry meat is considered a major source of human infection. In this study,
we characterize the infection biology and immune response to S. Virchow in chickens and
determine protection against homologous and heterologous re-challenge, with S. Virchow
or S. Typhimurium. Following oral infection of 7-day-old chickens, S. Virchow colonized the
gastrointestinal tract and the spleen. Infection elicited an increase in specific IgA, IgG, and
IgM antibodies and relative quantitative changes in several leukocyte populations, including
CD3, CD4, CD8α, CD8β, MHC II, KuL01, and γδTCR positive cells, both in the gastrointesti-
nal tract and systemically. Increased expression of pro-inflammatory cytokines IL-1β and
IL-6 and the chemokine CXCLi2 was also found. Primary infection with S. Virchow offered
limited systemic protection against re-challenge with S. Virchow or S. Typhimurium, but no
protection against cecal colonization. In conclusion,S.Virchow exhibits similar infection biol-
ogy and immune responses in the chicken to that previously described for S.Typhimurium.
Unlike S. Typhimurium, S. Virchow infection is poorly protective to homologous and het-
erologous re-challenge.These findings suggest that S. Virchow is capable of colonizing the
chicken well and therefore, presents a risk of entering the food chain in meat production.
Furthermore, the development of vaccines that protect effectively against S. Virchow and
indeed multivalent vaccines that protect across all Salmonella serogroups in the chicken
would appear to remain a challenging proposition.
Keywords:Salmonella infections, animal, vaccines, humoral immune response, cellular immune response, chicken,
cytokines
INTRODUCTION
One of the main sources of human non-typhoidal salmonellosis is
through the consumption of contaminated poultry meat and eggs
(1–3). Salmonella enterica serovar Enteritidis (S. Enteritidis) and
S. enterica serovar Typhimurium (S. Typhimurium) are the most
common serovars causing human foodborne salmonellosis world-
wide and are usually associated with mild gastroenteritis (4). Since
the 1990s,S. enterica serovar Virchow (S. Virchow) has increased in
prevalence in the UK and has been the third most frequent serovar
isolated from human cases in recent years (5, 6). S. Virchow infec-
tion is most commonly associated with gastroenteritis in humans,
but causes bacteremia more frequently than S. Typhimurium or
S. Enteritidis, especially in immuno-compromised patients and in
children (5–7). S. Virchow is one of the five serovars that have been
given priority by the European Union (EU) for control of entry
into the food chain, due to their significant risk to public health
(8–10).
In Israel, S. Virchow has a uniquely high prevalence and associ-
ation with invasive disease in humans (11, 12). In Switzerland,
it has been ranked between the 4th and 8th most frequently
isolated serovar between 2004 and 2009 and is a common cause
of human salmonellosis in Australia and other Oceanic countries
(13, 14). In other countries, including the United States, S. Vir-
chow gastroenteritis in humans is less common, but cases are
often associated with invasive infection (15). Increased antimi-
crobial resistance of S. Virchow has been reported in several
previous studies (16–20). Recent studies on Salmonella preva-
lence associated with developing poultry industries in Bangladesh
have also indicated S. Virchow to be a common problem (21,
22). Therefore, S. Virchow is a continuing and growing public
health problem worldwide, being associated with invasive dis-
ease in humans and showing high antimicrobial resistance to
therapeutic drugs.
Although S. Virchow is commonly isolated from chickens, its
mechanisms of invasion and pathogenic behavior is poorly under-
stood, as is the case with other serovars from serogroup C. A
previous study has shown that intravenous infection of poultry
with S. Virchow leads to systemic infection and colonization of
organs such as the spleen, to similar levels as S. Enteritidis and
S. Typhimurium (23). However, this study did not address oral
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infection, which is the more likely route of Salmonella infection
in poultry, via fecal–oral transmission in the chicken house. Addi-
tionally, previous studies have shown that S. Virchow can survive
in egg yolk, but has a limited ability to survive in albumen and on
egg shells, suggesting the main vehicle of transmission to humans
is poultry meat, rather than eggs (23, 24).
The aims of the current study were to characterize the infec-
tion biology of S. Virchow, following oral infection of chickens.
Additionally, we aimed to determine the humoral, cellular, and
cytokine response of the immune system following infection,
to obtain information for future immunologically based pre-
ventative or therapeutic approaches, following further research.
Finally, we aimed to get an indication of the protection and cross-
protection offered by primary infection with S. Virchow against




Salmonella Virchow 60 was selected from a panel of 12 previously
characterized S. Virchow isolates (25). S. Typhimurium F98 was
included in both infection experiments for a comparison, as it is
a well characterized strain in chickens (26–28). Bacterial strains
were grown from glycerol stocks maintained at −70°C, in 10 ml
LB broth, in an orbital shaking incubator overnight, at 37°C and
150 rpm.
EXPERIMENTAL ANIMALS
All work was conducted in accordance with UK legislation gov-
erning experimental animals under project license PPL 40/3063
and was approved by the University of Liverpool ethical review
process prior to the award of the license. Chicks were reared
in the high-biosecurity poultry unit, University of Liverpool, in
secure floor pens at a temperature of 30°C until 3 weeks of age,
then at 20°C. Birds were allowed ad libitum access to water and
vegetable protein-based laboratory poultry pelleted diet (SDS,
Witham, Essex, UK). All animals were checked a minimum of
twice daily to ensure their health and welfare.
EXPERIMENT 1: IMMUNOLOGICAL AND PATHOLOGICAL CHANGES
FOLLOWING INFECTION
One-day-old Rhode-Island Red chicks were obtained from the
Pirbright Institute, Compton, UK.
Forty-five chicks were housed separately, in 3 groups of 15
animals. At 7 days of age, Group 1 were orally challenged with
108 CFU S. Virchow 60 in LB broth, Group 2 were orally chal-
lenged with 108 CFU S. Typhimurium F98 in LB broth and Group
3 remained uninfected (controls). The chickens were checked twice
daily, for any signs of morbidity and for any mortality. At 5, 11,
and 26 days post infection (DPI), five chickens from each group
were randomly selected and killed by cervical dislocation for post
mortem examination. At post mortem examination, tissue sam-
ples were taken aseptically from the spleen and liver into sterile
weighed containers. The cecal contents were obtained by remov-
ing the caeca aseptically, then by emptying the digesta within each
cecum into a sterile container.
EXPERIMENT 2: PROTECTION AND CROSS-PROTECTION TO
RE-CHALLENGE
Forty-eight 1-day-old Rhode-Island Red chicks were housed sep-
arately in 2 groups of 24 animals. At 7 days of age, the chickens
in Group 1 were orally challenged with 108 CFU S. Virchow 60
in 0.3 ml LB broth. Group 2 remained uninfected as a control.
Chickens were checked twice daily, for any signs of morbidity
and for any mortality. To determine intestinal clearance of Sal-
monella, cloacal swabs were taken weekly from five randomly
selected chickens in each group. Swabs were directly plated onto
brilliant green agar (BGA) and then enriched in selenite broth for
Salmonella detection. BGA plates and enriched swabs were incu-
bated overnight at 37°C and the enriched swabs were re-plated
on BGA and incubated overnight at 37°C. Clearance of Salmo-
nella was found at 11 weeks post infection (WPI). At 13 weeks
post primary infection (WPPI), group 1 and group 2 were each
divided into groups of between 10 and 12 birds. Birds were
challenged or re-challenged with 108 CFU S. Virchow (Group
1= re-challenge, Group 3= challenge) or S. Typhimurium F98
(Group 2= re-challenge, Group 4= challenge). At 3 and 5 days
post-secondary infection, five or six chickens from each group
were randomly selected and killed by cervical dislocation for post
mortem examination and samples taken as described above.
ENUMERATION OF BACTERIA
During both infection experiments, cecal contents and spleens
were collected during necropsy for bacteriology and diluted 1:10
in 1×PBS. The spleen was homogenized using a MicroStomacher
80 (Seward, UK) and cecal contents were mixed using a vortex, to
form a suspension. Samples were serial-diluted in 1×PBS and
plated onto BGA. Plates were incubated for 18 h at 37°C and
the bacteria were enumerated. Negative samples were enriched
overnight at 37°C in selenite broth and then plated onto BGA, to
determine if samples contained Salmonella.
HISTOLOGICAL EXAMINATION
Samples of ileum and spleen from animals in experiment 1 were
fixed in 4% paraformaldehyde for 24–48 h, then trimmed and rou-
tinely paraffin wax embedded. Sections (3–5µm) were prepared
and stained with hematoxylin-eosin (HE) and independently
assessed histologically by two veterinary pathologists (Georgios
Nikolaou and Anja Kipar), to determine any histological changes
in response to infection (29).
PRODUCTION OF SOLUBLE SALMONELLA LYSATE ANTIGEN
Soluble Salmonella lysate antigen for each serovar was prepared
as described previously (28). Overnight cultures of S. Virchow 60
and S. Typhimurium F98, as described above, were used to inocu-
late 100 ml LB broth, which was then incubated overnight at 37°C
and 150 rpm. Cultures were aseptically poured into sterile tubes
and centrifuged at 4080× g for 25 min at 4°C to obtain bacterial
pellets. The supernatant was poured off and the bacterial pellet
was suspended in 20 ml 1×PBS. Bacterial suspensions were incu-
bated in a waterbath at 65°C for 5 h and a small aliquot was plated
onto nutrient agar and incubated at 37°C overnight, to confirm
no viable Salmonella remained. Following this, bacterial suspen-
sions were sonicated in 10 ml volumes in 20 s bursts on ice at an
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amplitude of 15µm, using a soniprep 150 (MSE Scientific Instru-
ments, UK), for a total of 10 times, allowing the suspension to
cool for 1 min between each burst. Suspensions were centrifuged
at 4080× g for 20 min at 4°C and then centrifuged at 30000× g
for 20 min at 4°C. Protein concentrations were measured using
the Bradford protein determination kit (Merck, Poole, UK). The
soluble antigen preparations were stored in aliquots at−20°C.
ENZYME-LINKED IMMUNOSORBENT ASSAY
Serum was obtained by removing blood from the heart at necropsy,
allowing it to clot, then removing the serum after centrifuging
at 13000× g for 5 min for. Serum samples were then stored as
aliquots at −20°C until used. Levels of serum specific antibod-
ies against S. Virchow and S. Typhimurium soluble antigen were
determined at each time point, as described previously (28, 30).
Each sample was run in triplicate. Flat-bottomed 96-well plates
were coated with 100µl/well of S. Virchow or S. Typhimurium sol-
uble antigen, diluted in carbonate–bicarbonate buffer (pH 9.6) to a
concentration of 16.2µg/ml and incubated overnight at 4°C. Sub-
sequently, the plates were washed three times with PBS Tween-20
(0.05%). They were then incubated with 3% blocking buffer (con-
sisting of 0.05% Tween-20 in PBS and 3% skimmed milk powder)
for 1 h at 37°C and washed with PBS Tween-20 (0.05%). Serum
samples were diluted in blocking buffer for the detection of IgA
(1:25), IgM (1:400), and IgG (1:400). Plates were incubated with
the diluted chicken serum for 1 h at 37°C and washed three times in
PBS Tween-20 (0.05%). Specific antibodies were detected by incu-
bating the samples with alkaline phosphatase conjugated to either
goat anti-chicken IgA (1:20000), IgM (1:1000), or IgG (1:2000)
(Serotec, Oxford, UK) diluted in blocking buffer, for 1 h at 37°C.
Plates were washed with PBS Tween-20 (0.05%) and incubated
with 100µl per well of p-nitrophenyl phosphate in the dark for
30 min at room temperature. The reaction was stopped by addi-
tion of 100µl 3N sodium hydroxide to each well. Absorbance was
determined using a microplate reader at 405 nm. Negative control
serum was obtained from Salmonella-free animals and positive
controls for S. Typhimurium were included using positive serum
from previous studies. No positive control was available for S. Vir-
chow at the start of the experiment, but a positive sample from the
first ELISA run was included on subsequent plates as a control to
ensure there was little variation from plate-to-plate.
IMMUNOHISTOCHEMISTRY
Spleen, ileum, and cecal tonsil were collected from all animals of
experiment 1 and snap frozen in liquid nitrogen on cork plates
in OCT (Tissue-tek, UK). Serial sections (10µM) were cut from
each sample, placed on poly-l-lysine coated slides (VWR Interna-
tional, UK) and fixed in acetone for 10 min. Tissue sections were
incubated overnight at 4°C with monoclonal antibodies against
chicken CD3, CD4, CD8α, CD8β, MHC II (B cells, antigen pre-
senting cells, macrophages, and monocytes) (31), KuL01 (mono-
cytes, macrophages, interdigitating cells, and activated microglia
cells) (31), γδ TCR and Bu1a (B cells and subsets of mono-
cytes and macrophages), antigens (Southern Biotechnology, Cam-
bridge, UK), and diluted 1:100 in 1×TBS (tris buffered saline).
A Vectastain Elite ABC kit (Vector Laboratories, Peterborough,
UK) was used for the detection of antibody binding. Sections
were incubated with the secondary antibody (biotinylated horse
anti-mouse, diluted 1:100 in 1×TBS) for 30 min at room temper-
ature. The reaction was visualized by incubating the slides with
3′3-diaminobenzidine, followed by counterstaining with Papani-
colaou’s hematoxylin and mounting with DPX mounting media
(VWR International).
Immunocytochemically stained sections were analyzed using a
Nikon Eclipse 80i microscope and NIS-elements BR 3 software.
From each sample, five high power fields (400×) of the spleen
and cecal tonsil were analyzed. The first field was from the cen-
ter of the tissue, followed by four fields around the central field.
Cells expressing the respective antigen were manually counted for
all five fields and then an average cell count was determined for
each chicken. A different approach was taken for the Bu1a+ cells as
these cells comprised the lymphatic follicles in the cecal tonsil. The
area of every stained follicle present on the tissue was measured
to determine if the follicles changed size over time, after infec-
tion. An average follicle area was calculated for each chicken. No
differences were found in the intensity of the inflammatory infil-
trate between the villous and crypt lamina propria; therefore, cell
counts were determined in the villi. Ten medium power (200×)
fields were analyzed per chicken; fields were selected in which
longitudinal sections of villi occupied the whole diameter of the
field. An average cell count from 10 fields was determined for each
chicken.
2−∆∆CT REAL-TIME RT-PCR FOR CYTOKINE EXPRESSION
From animals of experiment 1, spleen and cecal tonsil were col-
lected after euthanasia at 5, 11, and 26 DPI and stored in RNAlater
(Sigma-Aldrich, UK) at −20°C. Total RNA was prepared from
the tissue samples using an RNeasy kit and following the manu-
facturer’s instructions (Qiagen, UK). The transcription levels of
cytokines IL-1β, IL-6, IL-4, IFN-γ, and the chemokine CXCLi2
were determined using Rotor-Gene Q software v.4.14.2 (Qia-
gen, UK). Primers and probes for the selected cytokines and
chemokine have been described previously (32, 33). One-Step
RT-PCR was performed using the Rotor-Gene Probe RT-PCR
Master Mix (Qiagen; includes RT stage) in a final concentration
of 1× 0.25µl Rotor-Gene RT mix, 0.8µM of both the forward
and reverse primers, 0.2µM of the probe, and 1µl RNA made up
to a total volume of 25µl with RNase-free water. The following
cycling conditions were used for amplification: 50°C for 10 min,
95°C for 5 min, followed by 40 cycles of 95°C for 5 s and 60°C
for 10 s.
Each sample was run in triplicate and an average CT value was
taken for each group. The threshold for CT values was set between
0.20 and 0.23. CT values were normalized firstly to the endogenous
control and then to the uninfected control group (34). Expression
levels in the infected groups were represented as the fold-change
in expression compared to the uninfected control.
STATISTICAL ANALYSIS
Statistical analysis was performed using SPSS version 20.0 soft-
ware. Bacterial counts, immunohistochemical cell counts, and
RT-PCR CT values were compared using one-way ANOVA. Sig-
nificance between the values was taken if the P value was
<0.05.
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FIGURE 1 | Mean viable counts of S. Virchow and S.Typhimurium in
the cecal contents (A) and spleen (B) at 5, 11, and 26 DPI, following
infection of 7-day old chickens. Data shown are based on five birds per





Following primary infection, S. Virchow 60 and S. Typhimurium
F98 were found in the cecal contents at log10 8.0 CFU/g and log10
9.0 CFU/g at 5 DPI (Figure 1A). Bacterial counts in the caeca
peaked at 11 DPI, reaching levels of up to log10 9.0 CFU/g and
log10 12.0 CFU/g for S. Virchow and S. Typhimurium F98, respec-
tively. By 26 DPI, colony counts had begun to decline in both
infected groups.
Both S. Virchow 60 and S. Typhimurium F98 could be detected
in the spleen by 5 DPI, at log10 3.0 CFU/g and log10 2.0 CFU/g,
respectively (Figure 1B). Counts peaked at 11 DPI; however, no
Salmonella could be detected in the spleen of either infected group
by 26 DPI.
Experiment 2
No animals were lost as a result of infection, though three were
euthanized due to unrelated welfare issues. Clearance after pri-
mary S. Virchow infection occurred by 11 WPPI. At 13 WPPI,
Group 1 was divided and given a homologous or heterologous
re-challenge and Group 2 was divided and infected with S. Vir-
chow 60 or S. Typhimurium F98 for age-matched controls. At 3
and 5 days post challenge, the cecal content counts were lower in
the re-challenged groups compared to the age-matched control
groups (Figure 2A), although the difference in bacterial count
was not significant (P > 0.607). Viable Salmonella could not be
directly isolated from the spleen from any of the groups at either
time point. Therefore, spleen samples were enriched in selen-
ite broth and the percentage of positive and negative spleens
for each group was determined. The re-challenged groups were
FIGURE 2 | Mean viable counts of bacteria in the cecal contents (A)
and percentage of spleen positives following enrichment (B) at three
and five DPI, following re-challenge after primary S. Virchow infection.
Data shown are based on five birds per group at each time point. Group 1:
primary infection with S. Virchow, secondary infection with S. Virchow;
Group 2: primary infection with S. Virchow, secondary infection with S.
Typhimurium; Group 3: primary infection with S. Virchow; and Group 4:
primary infection with S. Typhimurium. Error bars represent the standard
error of the mean.
negative following enrichment, whereas at 3 days post challenge
20% of the S. Typhimurium age-matched control group were pos-
itive and at 5 days post challenge 40 and 60% of the S. Virchow
and S. Typhimurium age-matched control groups were positive,
respectively (Figure 2B).
HISTOPATHOLOGY
The histological examination of ileum and spleen from animals in
experiment 1, i.e., at 5, 11, and 26 DPI was undertaken to deter-
mine the type and degree of pathological changes in response to
S. Virchow infection. In most control animals, the ileum exhibited
scattered lymphocytes in the lamina propria mucose and occa-
sional lymphocyte exocytosis into the lamina epithelialis mucose.
In some animals, the mucosal infiltration was more prominent
(mild to moderate) and comprised not only lymphocytes, but also
macrophages and scattered heterophils. At 5 and 11 DPI, chickens
infected with either Salmonella strain exhibited a slight increase in
lymphocytes in the lamina propria, but the lamina epithelialis gen-
erally remained unaltered. Animals infected with S. Virchow also
exhibited occasional loose aggregates of heterophils in the lamina
propria mucose in particular in the villi.
Spleens exhibited a white pulp composed of small to mod-
erately sized lymphatic follicles without obvious germinal cen-
ter reaction, and inconspicuous T cell zones in all groups.
The red pulp was moderately cellular and contained some het-
erophils in a few control animals and generally a low to mod-
erate number of heterophils in chickens infected with either
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FIGURE 3 | Antigen-specific serum IgM (A), IgA (B), and IgG (C) against
S. Virchow and S.Typhimurium at 5, 11, and 26 DPI, following infection
of 7-day old chickens. Data shown are based on five birds per group at
each time point. Error bars represent the standard error of the mean. An
asterisk indicates that there was a significant difference between the S.
Virchow infected group and uninfected group (*) or the S. Typhimurium
infected group and the uninfected group (**) (P <0.05).




Specific IgM, IgG, and IgA antibodies were detected following
infection with both S. Virchow 60 and S. Typhimurium F98
(Figure 3). Between 5 and 11 DPI, serum IgM levels against S.
Virchow increased rapidly, peaking at 11 DPI. By 26 DPI, anti-
Salmonella IgM had declined toward levels found in the uninfected
group. IgA and IgG increased more slowly, but to greater levels
than IgM. Between 5 and 11 DPI, IgA levels against S. Virchow
increased slowly and were not considerably higher than in the
uninfected group. However, between 11 and 26 DPI, there was
a sharp increase in IgA and by 26 DPI, levels were considerably
higher than in the uninfected group. IgG levels against S. Virchow
increased steadily throughout the infection period. The IgA, IgM,
and IgG response against S. Virchow followed a pattern similar to
that seen against S. Typhimurium F98 throughout the experiment.
Experiment 2
At three and five DPI, serum samples were collected to determine
the specific IgA, IgG, and IgM production against S. Virchow 60
FIGURE 4 | Antigen-specific serum IgM (A), IgA (B), and IgG (C)
following primary and secondary infection of chickens with S. Virchow
and S.Typhimurium. Data shown are based on five birds per group at each
time point. Error bars represent the standard error of the mean. An asterisk
indicates that there was a significant difference between group 1 and group
2 (*) or group 3 and group 4 (**) (P <0.05).
and S. Typhimurium F98 after re-challenge, compared to age-
matched controls (Figure 4). Serum IgA antibody levels increased
in all four groups between 3 and 5 days post challenge, although
they were considerably higher in the re-challenged groups com-
pared to the age-matched controls. Serum IgG antibody levels
increased in all four groups between 3 and 5 days post challenge;
however, they were highest in the S. Virchow re-challenged group
at both time points. By 5 days post challenge, IgG levels were higher
in the re-challenged groups compared to the age-matched con-
trols. Serum IgM antibody levels decreased between 3 and 5 days
post challenge in all four groups. IgM titers were similar between
all four groups, although the highest IgM levels were found in the
S. Virchow re-challenged group, followed by the S. Typhimurium
re-challenged group.
CELLULAR RESPONSES
To quantify changes in the cellular immune response following
S. Virchow infection, spleen (Figure 5), ileum (Figure 6), and
cecal tonsil (Figure 7) specimens were collected from animals in

























































Salisbury et al. Immune response to Salmonella Virchow in the chicken
FIGURE 5 | Average number of CD3 (A), CD4 (B), CD8α (C), CD8β
(D), KuL01 (E), and γδTCR (F) positive cells/field in the spleen of
chickens during S. Virchow and S.Typhimurium infection
compared to in uninfected chickens. Data shown are based on
minimum of five birds per group at each time point (n=5 or 6) and five
fields of view per bird. Error bars represent the standard error of the
mean. The asterisk (*) indicates a significant difference between the
infected group and uninfected group.
experiment 1, euthanized at 5, 11, and 26 DPI. For the spleen, five
high power fields (40X) were selected and the positively stained
cells were manually counted. Immunocytochemistry showed that
at five DPI, numbers of CD4+, CD8α+, and KuL01+ cells were
increased in the spleen in chickens infected with S. Virchow, com-
pared to those in uninfected chickens, with the increase in CD4+
cells being significant (P < 0.05). At 11 DPI, CD4+, CD8α+, and
KuL01+ cells had increased further in the S. Virchow infected
group, to significantly higher amounts than those found in the
uninfected group (P < 0.003). By 26 DPI, CD8β+ cells had sig-
nificantly increased in the S. Virchow infected group above the
numbers found in the uninfected group (P < 0.0025). In contrast,
CD3+ and γδ TCR+ cells decreased in the spleen of S. Virchow
infected chickens, compared to the uninfected chickens at 5 DPI;
however, they had returned to levels similar to those found in the
uninfected group by 11 DPI.
For the ileum, 10 medium power fields (×200) were selected
and the cells were manually counted. An increase in CD4+,
CD8α+, CD8β+, and MHC II+ cells was observed at five DPI
in the S. Virchow infected group, in comparison to the uninfected
group, with the increase in CD4+ and MHC II+ cells being signif-
icant (P < 0.028). CD4+, CD8α+, CD8β+, and MHC II+ cells
increased further in the S. Virchow infected group at 11 DPI,
when a significant increase in KuL01+ and γδ TCR+ cells was
also found (P < 0.016). At 26 DPI, CD4+, MHC II+, CD8β+,
and KuL01+ cells were still elevated in the S. Virchow infected
group; however, CD8α+ and γδ TCR+ cells had returned to lev-
els similar to those seen in the uninfected group. In the ileum,
the number of several cell populations was higher in the S. Vir-
chow infected group compared to the S. Typhimurium infected
group and the uninfected group. Although the number of CD4+
cells were increased in both infected groups at each time point,
they were considerably higher in the S. Virchow infected group.
CD8α+ and CD8β+ cells were increased in the infected groups
throughout the infection experiment; however, the cell counts were
significantly higher, for both subpopulations, in the S. Virchow
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FIGURE 6 | Average number of CD4 (A), CD8α (B), CD8β (C), MHC II
(D), KuL01 (E), and γδTCR (F) positive cells/field in the ileum of
chickens during S. Virchow and S.Typhimurium infection compared
to in uninfected chickens. Data shown are based on minimum of 5
birds per group at each time point (n=5 or 6) and 10 fields of view per
bird. Error bars represent the standard error of the mean. The asterisk
(*) indicates a significant difference between the infected group and
uninfected group.
infected group compared to the S. Typhimurium infected group
and the uninfected group at 11 DPI (P < 0.036). MHC II+ cells
were significantly more numerous in the infected groups at 5
(P < 0.028) and 11 (P < 0.011) DPI and numbers remained higher
than those of the uninfected group at 26 DPI. At 11 DPI, a sig-
nificant increase was seen in KuL01+ (P < 0.016) and γδ TCR+
(P < 0.001) cells in both of the infected groups and was still seen
at 26 DPI.
For the cecal tonsil, five high power fields (×400) were selected
and the positively stained cells were counted manually. The quan-
tity of CD3+, CD8β+, and KuL01+ cells had increased in the S.
Virchow infected group by five DPI, with the number of CD3+
and KuL01+ cells being significantly higher than in the unin-
fected group (P < 0.016). At 11 DPI, CD3+, KuL01+ cell num-
bers had increased further in the S. Virchow infected group. A
significant increase was also found in CD4+ cells (P < 0.05).
At 26 DPI, KuL01+ cells were still significantly higher in the
S. Virchow infected group compared to the uninfected group.
Throughout the infection period MHC II+ cells were signifi-
cantly lower in the S. Virchow infected group compared to the
uninfected group (P < 0.045). The size of the Bu1a+ follicles had
increased in the S. Virchow infected group by 5 DPI and had
increased further at 11 DPI (P < 0.036). Alterations in the cell
numbers in the S. Virchow infected group were similar to those in
the S. Typhimurium F98 infected group, throughout the infection
period.
CYTOKINE AND CHEMOKINE EXPRESSION
The change in expression of key cytokines and chemokines was
determined in the spleen (Figure 8) and cecal tonsil (Figure 9),
at each time point, throughout Experiment 1. The magnitude of
the response sometimes varied within groups, which can be seen
by the standard error bars. These findings have been reported
previously (28).
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FIGURE 7 | Average number of CD3 (A), CD4 (B), CD8α (C), CD8β (D), MHC
II (E), KuL01 (F), γδTCR (G), and Bu1a (H) positive cells/field in the cecal
tonsil of chickens during S. Virchow and S.Typhimurium infection
compared to in uninfected chickens. Data shown are based on minimum of
five birds per group at each time point (n=5 or 6) and five fields of view per
bird. Error bars represent the standard error of the mean. The asterisk (*)
indicates a significant difference between the infected group and uninfected
group.
In the spleen, IL-1β, IL-6, and CXCLi2 mRNA levels were
increased in the S. Virchow infected group above those of the
uninfected group, by 4.23, 5.90, and 2.99-fold, respectively, at five
DPI. They were also increased in the S. Typhimurium F98 infected
group above those of the uninfected group, by 7.58, 7.62, and
3.46-fold, respectively, with the increase in IL-1β and IL-6 being
significant. At 11 DPI, IL-1β, IL-6, and CXCLi2 transcription in
the infected groups had returned to levels similar to those seen
in the uninfected group. IFN-γ levels were increased in spleens of
the S. Virchow infected group at 11 DPI by 2.19-fold. IL-4 was
not expressed in the spleen at any time point during the infection
period.
In the cecal tonsil, the IL-1β mRNA level was increased by
1.46-fold in the S. Virchow infected group at five DPI. IL-1β
transcription was variable in the S. Typhimurium infected group,
with two chickens showing a 6.19-fold increase and three chick-
ens showing no change at five DPI. A 1.25-fold increase in the
IL-6 mRNA level was found in 3/5 S. Virchow infected chickens at
five DPI; however, IL-6 expression in the S. Typhimurium infected
group did not change in comparison to the uninfected group.
CXCLi2 expression was higher in the S. Virchow infected group
than the uninfected group at each time point and had increased
7.73, 1.65, and 1.80-fold at 5, 11, and 26 DPI, respectively. The
increase in CXCLi2 in the S. Virchow infected group compared
to the uninfected group was significant at five DPI. CXCLi2 tran-
scription had increased by an average of 5.39-fold in two birds
from the S. Typhimurium F98 infected group at five DPI. IFN-γ
levels increased slightly in the S. Virchow infected group by 1.29,
1.34, and 1.56-fold at 5, 11, and 26 DPI, respectively. In the S.
Typhimurium infected group, IFN-γ expression was similar to the
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FIGURE 8 | Relative expression of IFN-γ (A), CXCLi2 (B), IL-1β (C),
and IL-6 (D) in the spleen of chickens infected with S. Virchow
and S.Typhimurium F98 compared to uninfected chickens, at 5,
11, and 26 DPI. Data shown are based on minimum of five birds per
group at each time point (n=5 or 6). Error bars represent standard
error of the mean. An asterisk (*) indicates that there was a
significant fold-change between the infected group and the
uninfected group.
uninfected group at five DPI; however, it had increased by three-
fold at 11 DPI. At 26 DPI, IFN-γ expression had decreased and was
1.33-fold higher than in the uninfected group. IL-4 expression was
not detected in the cecal tonsil for the duration of the experiment.
DISCUSSION
Previously, we demonstrated that S. Virchow can colonize the gas-
trointestinal tract and the spleen of chickens, to levels similar to
those seen with S. Typhimurium at three DPI, suggesting S. Vir-
chow may mirror the infection biology found with broad-range
serovars (25). Here, we have further characterized the S. Virchow
colonization of poultry and confirm that it exhibits an infection
biology similar to S. Typhimurium, over an infection period of
26 days. S. Virchow colonized the gastrointestinal tract and the
spleen by 5 DPI, with bacterial counts peaking in the gut and
systemically at 11 DPI. By 26 DPI, S. Virchow had been cleared
from the spleen, showing that it causes transient systemic infec-
tion; however, bacterial counts were still high in the cecal contents.
As with S. Typhimurium F98, chickens infected with S. Virchow
showed no signs of clinical illness and no significant pathological
changes in the ileum during the infection period, suggesting its
low pathogenicity in this host. Although, both S. Virchow and S.
Typhimurium have been shown to be invasive, depending on the
strain and the host they are infecting (35–39).
The histological analysis of the ileum and spleen did not reveal
marked pathological changes at 5, 11, and 26 DPI and no dis-
tinct evidence of epithelial damage in the ileum. A slight increase
in lymphocyte infiltration and some heterophil recruitment was
seen in the ileum together with evidence of systemic heterophil
release, based on the general mild increase in heterophils in the
splenic red pulp at the two earlier time points. Our findings dif-
fer from those of a previous study, which examined the effect of S.
Typhimurium in the intestine of 40-day old white leghorn chickens
up to four DPI and observed evidence of epithelial damage and a
more pronounced mononuclear infiltration (40). The author also
found large numbers of heterophils in the intestinal lumen. How-
ever, only small numbers of heterophils were seen in the lamina
propria that would be more consistent with our findings on day
5. It can also not be excluded that age and breed play a role in the
response to infection. The fact that we observed evidence of sys-
temic and local heterophil recruitment after infection is consistent
with a more recent study indicating the relevance of heterophils in
the innate response to bacterial, including Salmonella, infection in
chickens (41, 42).
To our knowledge, this is the first detailed study of the humoral,
cellular, and cytokine response produced by chickens in response
to oral infection with S. Virchow. The results show that S. Virchow
stimulates an immune response in chickens similar to that seen
by other broad-range serovars. This suggests that serogroup has
limited influence on innate or adaptive immune responses beyond
the change in specificity of response to LPS. Indeed recent deter-
mination of the innate response to another serogroup C serovar, S.
Infantis, supports the notion that the immunobiology of infection
in the chicken is similar with all invasive broad host range serovars
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FIGURE 9 | Relative expression of IFN-γ (A), CXCLi2 (B), IL-1β (C),
and IL-6 (D) in the cecal tonsil of chickens infected with S.
Virchow and S.Typhimurium F98 compared to uninfected
chickens, at 5, 11, and 26 DPI. Data shown are based on minimum
of five birds per group at each time point (n=5 or 6). Error bars
represent standard error of the mean. An asterisk (*) indicates that
there was a significant fold-change between the infected group and
the uninfected group.
(43, 44). After S. Virchow infection, numbers of CD4+, CD8α+,
and CD8β+ cells had increased in the ileum by five DPI, indicating
a T helper and a cytotoxic T cell response had occurred. Previous
studies have found variation in T cell influx into the gut, depend-
ing on location in the gastrointestinal tract, infection dose, age of
the host at the time of infection, and the genetic background of
the host (45–48).
MHC II+ cells increased in number in the ileum throughout
the experiment and correlated with an increase in KuL01+ cells,
suggesting local recruitment of macrophages and the likely role
of antigen presenting cells in the control of S. Virchow infec-
tion. At 11 DPI, the quantity of γδ TCR+ cells increased in the
ileum in both infected groups; however, the number of cells in
the S. Virchow infected group was significantly higher than in
the S. Typhimurium infected group and the uninfected group
(P =< 0.001). An early increase in γδ TCR+ cells in the cecum
has been shown previously, following infection of chicks with S.
Typhimurium, S. Enteritidis, and S. enterica serovar Hadar (S.
Hadar) (47, 49). The difference between time points during this
study and previous studies may be due to different areas of the gut
being sampled.
The changes in the proportion of leukocyte subpopulations
were less prolonged in the cecal tonsil, compared to the ileum.
CD3+ and CD8β+ cell numbers increased early in the infected
groups, by 5 DPI, followed by an increase in CD4+ cells at 11
DPI and CD8α+ cells by 26 DPI. An increase of CD4+ cells in
the cecal tonsil, following S. Enteritidis infection, has been previ-
ously associated with immunoglobulin class switching (50). This
mechanism could explain why, in this study, CD4+ cells were only
up-regulated in the cecal tonsil at one time point. The size of the
lymphatic follicles which were comprised of Bu1a+ B cells in the
cecal tonsil was increased in the infected groups compared to the
uninfected group at 5 and 11 DPI, indicating the humoral immune
response has a role in clearance of Salmonella infection. Through-
out the infection experiment, MHC II+ cells decreased, whereas
KuL01+ cells increased, in the cecal tonsil. An increase in KuL01+
cells in the cecal tonsil following S. Enteritidis infection has been
shown previously (43) and could indicate antigen presentation to
immune cells in the cecal tonsil.
CD4+ and CD8α+ cell numbers increased in the spleen in
infected groups and remained elevated for the duration of the
experiment. CD8β+ cells did not increase in the spleen until 26
DPI in the infected groups. Varying results have been found for
these subpopulation changes in the spleen and could be a result of
age of the chickens when infected, infecting serovar or dose (45,
50, 51). At five DPI, the number of CD3+ and γδ TCR+ cells (T
cells) was decreased in the spleen in the infected groups. A decrease
of lymphocytes in the spleen has been shown to coincide with an
increase in the cecum following S. Enteritidis infection (45) and
could indicate cell-trafficking from the spleen to the gut.
Changes in IFN-γ, CXCLi2, IL-1β, and IL-6 transcription were
found in the spleen and cecal tonsil during S. Virchow and S.
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Typhimurium infection; although, the magnitude of the response
varied within groups. This was particularly evident in the cecal
tonsil, as some chickens would exhibit a response, whereas oth-
ers would not. Variability in cytokine and chemokine response in
the cecal tonsil within the same group has been shown in pre-
vious studies and may be due to differences in immunological
maturation from chicken to chicken (28, 50).
An increase in IL-1β, IL-6, and CXCLi2 in the spleen and cecal
tonsil of chickens occurred by 5 DPI, in both infected groups,
showing that a rapid inflammatory response occurs against S. Vir-
chow, in a similar manner to S. Typhimurium. IL-6 remained
elevated in the spleen until 26 DPI, which has previously been
associated with lymphocyte and macrophage development, rather
than an acute inflammatory response (30). CXCLi2 is a pro-
inflammatory chemokine that is highly homologous to human
IL-8 and is important for early immune responses in the gut,
including an influx of heterophils (52–54). The increase in IL-
1β, IL-6, and CXCLi2 transcription in the spleen and cecal tonsils
shows that like S. Typhimurium and other broad-range serovars,
S. Virchow elicits a strong immune response in the chicken, caus-
ing a rapid inflammatory response upon infection. The response
elicited is unlike that seen with host-restricted serovars, such as S.
enterica serovar Pullorum (S. Pullorum) and S. enterica serovar
Gallinarum (S. Gallinarum), which do not induce inflammatory
responses and rely on “stealth” to invade and cause systemic or
typhoidal-like disease (55).
IFN-γ expression was modestly increased in both infected
groups compared to the uninfected group at every time point,
in both the spleen and cecal tonsil. IFN-γ enhances the oxidative
burst in macrophages against Salmonella infection (56). Elevated
levels of IFN-γ support the idea that S. Virchow clearance is
dependent on IFN-γ T cell mediated responses. The increased
level of IFN-γ, in combination with the lack of IL-4 expres-
sion (Th2 cytokine) (57), suggests S. Virchow clearance is, like
S. Typhimurium, primarily Th1-mediated.
Serum humoral responses showed a classical pattern of a
rapid rise in IgM, followed by a rise in IgG and IgA, against S.
Virchow infection. The humoral immune response was slightly
stronger against S. Typhimurium than S. Virchow throughout the
infection experiment, although it did follow the same pattern in
both infected groups. Increased serum antibodies and increased
amounts of B cells (Bu1a+) in the cecal tonsil suggest the humoral
response has a role in S. Virchow clearance, although previous
studies have shown it is not needed for Salmonella clearance (58,
59).
The bacteriology results from Experiment 2 showed primary
infection with S. Virchow offers some protection against systemic
spread, following secondary infection, but no significant reduc-
tion in cecal colonization. Additionally, primary infection with
S. Virchow offered cross-serogroup protection against systemic
spread, following secondary infection with S. Typhimurium, but
no protection against colonization of the gut.
Salmonella-specific IgA, IgG, and IgM were detected follow-
ing challenge in all four infected groups but levels were always
highest in the S. Virchow homologous re-challenge group (Group
1). These results are indicative of an antigen-specific secondary
immune response in previously challenged birds. Additionally,
the quicker and greater antibody response observed in the S.
Typhimurium heterologous re-challenge group (Group 2) com-
pared to the age-matched S. Typhimurium infected group (Group
4) indicates a degree of immunological cross-reactivity against S.
Virchow and S. Typhimurium, though little protection.
A previous study, investigating the cross-protection and cross-
reactivity against S. Typhimurium and S. Enteritidis infection
found reduced cecal content and splenic bacterial counts following
re-challenge, compared to the age-matched controls (60). Cross-
protection offered by primary infection with S. Typhimurium
against secondary infection with S. Enteritidis was more effec-
tive than vice versa (60). In addition to this study, an earlier
one looked at the degree of cross-protection in mice, focusing
on the protection conferred by the main LPS O antigen. Primary
infection with S. Typhimurium or S. Enteritidis gave high pro-
tection against homologous re-challenge; however, no protection
against challenge with the heterologous serotype. Here, we show
some evidence of cross-protection elicited by S. Virchow against
systemic infection, following heterologous re-challenge with S.
Typhimurium, but no cross-protection against cecal colonization.
It is possible that S. Typhimurium may have protected more effec-
tively against secondary infection with S. Virchow, but our findings
suggest there is limited cross-protection to intestinal infection
between Group B and C serovars of S. enterica, suggesting that
effective multivalent vaccines for use in controlling Salmonella in
poultry will be difficult to achieve. However, both the study by
Beal et al. (60) and a recent vaccination study have demonstrated
a degree of cross-protection between serogroups B and D (60, 61).
The use of the live attenuated S. Enteritidis vaccine, Gallivac® Se,
alone or in combination with the S. Enteritidis–S. Typhimurium
inactivated vaccine, Gallimune® Se+ St, prior to infection with
either S. Typhimurium or S. Enteritidis, resulted in a significant
reduction in liver and cecal content colonization in the vaccinated
compared to unvaccinated chickens (61).
Overall, the findings in this study have shown that S. Vir-
chow colonizes chickens and stimulates an inflammatory immune
response, similar to that found with broad-range serovars. S. Vir-
chow colonized the ileum of chickens to high levels and caused
transient systemic infection. The chickens exhibited no clinical
symptoms and this, in combination with the only mild histologi-
cal changes indicates S. Virchow has low pathogenicity in chickens.
Although the present study has shown that S. Virchow has similar
infection biology to broad-range serovars, it is rarely isolated from
sources other than humans and chickens (13, 62). In contrast, S.
Typhimurium is commonly isolated from many species including
humans, chickens, pigs, cattle, mice, and domestic animals (63).
Although S. Virchow could cause disease in these hosts and showed
similar infection biology to S. Typhimurium, it is therefore, likely
to be more host-adapted than S. Typhimurium.
Salmonella Virchow stimulated an acute inflammatory
response in chickens, including a rapid increase in IL-1β, IL-6,
and CXCLi2 transcription. Evidence of an IFN-γ T cell mediated
response was also apparent. An increase in IFN-γ and a lack of
IL-4 suggests the immune response against S. Virchow is primar-
ily Th1-mediated, although a strong antibody response is elicited
by S. Virchow. However, unlike S. Typhimurium or S. Enteritidis,
primary infection with S. Virchow offers only limited protection
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against homologous re-challenge with S. Virchow or heterologous
challenge with S. Typhimurium. This suggests developing effective
vaccines to S. Virchow or multivalent cross-serogroup vaccines in
the chicken may prove problematical. Nevertheless, the findings
in this study present valuable information showing the immune
responses produced by chickens against S. Virchow and could
be built on to enable immunological preventative or therapeutic
approaches against the serovar.
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